(Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today highlighted capabilities of its ...
A 2026 review found encouraging diagnostic results for DNA methylation biomarkers in ovarian cancer but concluded that ...
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
My encounter with Rascal Does Not Dream was in 2018.In other words, I've been with it since the anime aired.I still love the ...
Cladophialophora bantiana, a neurotropic black mold with a 60%-70% fatality rate, surged nearly fourfold in U.S. detections ...
An Indian-origin man, Rajesh Patel, has been charged with wire fraud for allegedly submitting $66.2 million in fake COVID-19 test claims to a federal program.
A 2026 narrative review finds that rapid point-of-care technologies can detect pathogens and resistance markers closer to ...
For those who want to organize formats like FASTQ, SAM, and GO, as well as calculations in life sciences and information ...
Approval based on AZUR-1 data showing clinically significant proportion of participants with no detectable signs of cancer one year or more after treatment No disease recurrences reported ...
Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease
A 2026 review maps targeted therapy across EGFR, ALK, ROS1, KRAS, MET, RET and other NSCLC drivers, including resistance and ...
A laboratory shopping list can include a freezer, a case of pipette tips, a replacement milling jar, and a high-purity ...
Pertussis all but disappeared during the height of the COVID-19 pandemic, then resurged across multiple WHO regions between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results